The Covid-19 vaccine script that TV shows are using to fight fear and misinformation
As doctors and health professionals race against Covid-19 vaccination skepticism, some Hollywood producers, writers and showrunners are betting that inputting vaccines into television storylines can help curb widespread misinformation.Source: CNBC
Yale Cancer Center Partners in Fight to Help Eliminate HPV-related Cancers
Yale Cancer Center joins the Association of American Cancer Institutes (AACI) and its partner organizations to endorse a Call to Action for our nation to work together toward the elimination of human papillomavirus (HPV)-related cancers.
Opportunities to vaccinate young women against HPV missed at alarming rate
en aged 18-26 who were eligible to receive Human Papilloma Virus (HPV) vaccine have missed at least one opportunity to receive the vaccine during a visit to an obstetrics and gynecology clinic, Yale researchers report. This study also confirms previous research showing racial disparities in vaccination for HPV: Women who identify as black are 61% more likely have had a missed opportunity than women who identify as white. These findings are published in the American Journal of Obstetrics and Gynecology. HPV is a well-known cause of pre-cancerous cervical lesions, which, if untreated, could develop into cervical cancer. Immunization against HPV has been shown to be safe and effective in preventing these pre-cancerous lesions. The two-dose HPV vaccine is recommended for administration to It is recommended that girls ages 11-12 receive the two-dose HPV vaccine, and that those through age 26 receive the three-dose vaccination for “catch-up.”
$1.8 Million Granted to Yale School of Public Health to Study Effectiveness of HPV Vaccine
A $1.8 million National Institutes of Health grant will help researchers at the Yale School of Public Health shed light on the real-world effectiveness of the Human Papillomavirus (HPV) vaccine. Results of this study can ultimately help to maximize the vaccine’s impact on several types of cancer.
Precancerous Lesions Associated with HPV Dropping in Connecticut, YSPH Study Finds
The vaccine for the Human Papillomavirus (HPV) is proving to have significant population-level effects in Connecticut, with rates of precancerous lesions caused by HPV down drastically among young women, a new Yale School of Public Health study finds.
The Answer to Stopping the Coronavirus May Be Up the Nose
The Covid-19 vaccines authorized for use today were developed at unprecedented speed and surpassed expectations in how well they worked. The billions of people who are protected by them have avoided severe symptoms, hospitalization and deaths. These vaccines are a scientific success beyond measure. And yet they could be even better.Source: The New York Times
Experts question unusual authorization plan for Covid vaccine for kids under 5
The Food and Drug Administration’s willingness to consider authorizing a Covid-19 vaccine developed by Pfizer and BioNTech for children under the age of 5 — without evidence yet that it would be protective — is raising concerns among some vaccine experts who fear the plan could backfire and undermine vaccine uptake in this group.Source: Stat
Responding to Omicron: Aggressively Increasing Booster Vaccinations Now Could Prevent Many Hospitalizations and Deaths
Immediately doubling the December pace of boosters to 1.5 million per day could prevent approximately 41,000 deaths and more than 400,000 hospitalizations by the end of April.Source: The Commonwealth Fund
FDA Authorizes COVID Vaccine Booster Shots for Kids Aged 12 to 15 as Pediatric Cases Soar
The Food and Drug Administration has authorized COVID-19 vaccine booster shots for kids aged 12 to 15 years old, they announced Monday, as pediatric cases soar and children head back to school after the holidays.Source: People